Ascendis Pharma ADR (ASND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -114,083 | -76,508 | -50,858 | -140,041 | -105,450 |
| Depreciation Amortization | 734 | 474 | 243 | 830 | 631 |
| Accounts receivable | 194 | 204 | 189 | 112 | -185 |
| Accounts payable and accrued liabilities | 8,415 | 15,312 | -7,823 | 12,156 | 7,703 |
| Other Working Capital | -426 | 15,200 | -8,553 | 5,674 | 1,376 |
| Other Operating Activity | -14,871 | -22,482 | 21,640 | 13,778 | 12,546 |
| Operating Cash Flow | $-120,037 | $-67,801 | $-45,161 | $-107,490 | $-83,378 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,845 | -521 | -125 | -1,064 | -830 |
| Investing Cash Flow | $-1,845 | $-521 | $-125 | $-1,064 | $-830 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 250,515 | 254,489 | 258,163 | 150,453 | 135,753 |
| Other Financing Activity | -15,252 | -15,645 | -16,125 | -9,481 | -8,474 |
| Financing Cash Flow | $235,263 | $238,844 | $242,038 | $140,972 | $127,279 |
| Exchange Rate Effect | 20,309 | 17,014 | -8,612 | -15,439 | -12,557 |
| Beginning Cash Position | 227,135 | 232,976 | 240,125 | 203,826 | 211,941 |
| End Cash Position | 360,824 | 420,512 | 428,266 | 220,805 | 242,455 |
| Net Cash Flow | $133,690 | $187,536 | $188,140 | $16,979 | $30,514 |
| Free Cash Flow | |||||
| Operating Cash Flow | -120,037 | -67,801 | -45,161 | -107,490 | -83,378 |
| Capital Expenditure | -1,845 | -521 | -125 | -1,064 | -830 |
| Free Cash Flow | -121,882 | -68,322 | -45,286 | -108,554 | -84,208 |